Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

Clinical and Experimental Metastasis

Volumn 22, Issue 1, 2005, Pages 47-59

  Borowsky, Alexander D ^a,b   Namba, Ruria ^a   Young, Lawrence J T ^a,b   Hunter, Kent W ^c   Hodgson, J Graeme ^d   Tepper, Clifford G ^a   McGoldrick, Erik T ^a,b   Muller, William J ^e   Cardiff, Robert D ^a,b   Gregg, Jeffrey P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Akt; Breast; Breast carcinoma; Cell line metastasis; Comparative genomic hybridization; ERBB2; Gene expression analysis; LY294002; Mammary fat pad; Mouse mammary tumor virus long terminal repeat; Oncogene; Orthotopic; Phosphatidylinositol 3 kinase

Indexed keywords

DNA; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER CELL CULTURE; CANCER GRAFT; CANCER GROWTH; CANCER INVASION; CELL INTERACTION; CELL STRUCTURE; CONTROLLED STUDY; DNA CONTENT; GENE EXPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MITOSIS RATE; MOUSE; MOUSE STRAIN; NONHUMAN; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN;

EID: 23944481105     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-2908-5     Document Type: Article

References (37)

1. A Jemal RC Tiwari T Murray 2004 Cancer statistics, 2004 CA Cancer J Clin 54 8 29
2. RD Cardiff MR Anver BA Gusterson 2000 The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting Oncogene 19 968 88
3. CT Guy RD Cardiff WJ Muller 1992 Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease Mol Cell Biol 12 954 61
4. EY Lin JG Jones P Li 2003 Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases Am J Pathol 163 2113 26
5. JE Maglione D Moghanaki LJ Young 2001 Transgenic polyoma middle-T mice model premalignant mammary disease Cancer Res 61 8298 305
6. H Baribault M Wilson-Heiner W Muller 1997 Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours Transgenic Res 6 359 67
7. RA Graham JR Morris EP Cohen 2001 Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5′ MUCI promoter sequence and the middle T oncogene, expressed from the MMTV promoter Int J Cancer 92 382 7
8. Y Li B Welm K Podsypanina 2003 Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells Proc Natl Acad Sci USA 100 15853 8
9. KA Jessen SY Liu CG Tepper 2004 Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin Breast Cancer Res 6 R157 R69
10. D Cozma L Lukes J Rouse 2002 A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers Genome Res 12 969 75
11. TM Williams F Medina I Badano 2004 Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J Biol Chem 279 51630 46
12. GD Basu LB Pathangey TL Tinder 2004 Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer Mol Cancer Res 2 632 42
13. T Le Voyer Z Lu J Babb 2000 An epistatic interaction controls the latency of a transgene-induced mammary tumor Mamm Genome 11 883 9
14. MA Webster JN Hutchinson MJ Rauh 1998 Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis Mol Cell Biol 18 2344 59
15. J Hutchinson J Jin RD Cardiff 2001 Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression Mol Cell Biol 21 2203 12
16. AT Cheung LJ Young PC Chen 1997 Microcirculation and metastasis in a new mouse mammary tumor model system Int J Oncol 11 69 77
17. SL Friedman FJ Roll 1987 Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan Anal Biochem 161 207 18
18. CJ Vlahos WF Matter KY Hui 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) J Biol Chem 269 5241 8
19. R Namba JE Maglione LJ Young 2004 Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ Mol Cancer Res 2 453 63
20. C Li WH Wong 2001 Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection Proc Natl Acad Sci USA 98 31 6
21. G Hodgson JH Hager S Volik 2001 Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas Nat Genet 29 459 64
22. JH Hager JG Hodgson J Fridlyand 2004 Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas Cancer Res 64 2406 10
23. A Rosner K Miyoshi E Landesman-Bollag 2002 Pathway pathology: Histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors Am J Pathol 161 1087 97
24. C Montagna MS Lyu K Hunter 2003 The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines Cancer Res 63 2179 87
25. YP Shi G Mohapatra J Miller 1997 FISH probes for mouse chromosome identification Genomics 45 42 7
26. AK Man LJ Young JA Tynan 2003 Ets2-dependent stromal regulation of mouse mammary tumors Mol Cell Biol 23 8614 25
27. RH Weiss D Marshall L Howard 2003 Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1) Cancer Lett 189 39 48
28. LY Bourguignon Z Gunja-Smith N Iida 1998 CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells J Cell Physiol 176 206 15
29. DH Lau L Xue LJ Young 1999 Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer Cancer Biother Radiopharm 14 31 6
30. MA Webster WJ Muller 1994 Mammary tumorigenesis and metastasis in transgenic mice Semin Cancer Biol 5 69 76
31. TH Qiu GV Chandramouli KW Hunter 2004 Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease Cancer Res 64 5973 81
32. DJ Slamon W Godolphin LA Jones 1989 Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707 12
33. SM Dilworth 2002 Polyoma virus middle T antigen and its role in identifying cancer-related molecules Nat Rev Cancer 2 951 6
34. G Zhang B He GF Weber 2003 Growth factor signaling induces metastasis genes in transformed cells: Molecular connection between Akt kinase and osteopontin in breast cancer Mol Cell Biol 23 6507 19
35. Khanna C, Hunter K. Modeling metastasis in vivo. Carcinogenesis 2004.
36. RS Kerbel 1998 What is the optimal rodent model for anti-tumor drug testing? Cancer Metastasis Rev 17 301 4
37. JE Maglione ET McGoldrick Lj Young 2004 Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes Mol Cancer Ther 3 941 53